To determine whether injection of hCG or GnRH-agonist on d 5 after estrus ( d 0 ) has a differential functional effect on an induced and the original corpus luteum (CL), two experiments were conducted. In Exp. 1, nonlactating Holstein cows were injected on d 5 with saline ( n = 4; T1), a GnRHagonist (Buserelin ® , 8 mg i.m.; n = 4; T2), or hCG (1,000 IU, i.v., and 2,000 IU, i.m.; n = 4; T3). Induced CL were removed on d 13 and weights were different (GnRH-agonist < hCG). In vitro production of progesterone by CL tissue ( mg/g; mg/CL) was affected by treatment (GnRH-agonist < hCG) and dose of LH (ng/mL) in culture media. Experiment 2 was a replicate of Exp. 1, except that the original CL was removed on d 17 for in vitro culture. Day-17 CL weights and in vitro production of progesterone by original CL were not affected by treatment. The daily rate of increase of plasma progesterone from d 6 to d 13 differed: saline < GnRH-agonist < hCG ( P < .01). From d 14 to 17, the rate of plasma progesterone decrease was not different between treatments. Electron micrographic study of the original and induced CL indicates that LH-like exposure delays involution of steroidogenic luteal cells. In summary, the higher levels of progesterone from d 6 to d 13 of the estrous cycle following an injection of hCG vs GnRH-agonist on d 5 is due to a greater response of hCG-induced CL.
Introduction
Administration of hCG (Price and Webb, 1989; Howard and Britt, 1990; Rajamahendran and Sianangama, 1992; Diaz et al., 1993; Fricke et al., 1993) between d 4 and 7 of the estrous cycle induced ovulation of the first-wave dominant follicle and formation of an induced corpus luteum ( CL) . Similarly, injection of GnRH on d 6 (Webb et al., 1992) or a GnRH-agonist on d 5 of the estrous cycle caused ovulation of the first-wave dominant follicle with formation of an induced CL. Interestingly, when a CL was induced after administration of hCG or a GnRH-agonist on d 5 of the estrous cycle, plasma concentrations of progesterone for the hCG-treated heifers were greatly increased compared to those of the GnRH-agonist-treated heifers .
Objectives of the present experiments were 1 ) to determine whether injections of GnRH-agonist or hCG on d 5 of the estrous cycle had differential effects on luteal phase concentrations of plasma progesterone in the presence or absence of induced CL; 2 ) to assess in vitro progesterone production of the GnRH-agonist or hCG-induced CL; 3 ) to perform a histological evaluation of the GnRH-agonist-and hCG-induced and original CL relative to number and percentage of different luteal cells among experimental corpora lutea.
Materials and Methods
Animal Management. Both experiments were conducted at the Dairy Research Unit of the University of Florida (Hague). Nonlactating Holstein cows were kept in a lot with minimal pasture and fed peanut hay and corn silage. Ovaries and reproductive tracts were palpated per rectum before initiation of the treatment to confirm presence of a CL and eliminate any cow presenting gross morphological anomalies. In the first experiment, cows ( n = 24) with a palpable CL were synchronized to estrus by insertion and retention of a norgestomet ear implant (Syncro-Mate B; implant containing 6 mg of norgestomet; Sanofi Laboratories, Overland Park, KS) for 7 d and an injection of PGF 2a (Lutalyse ® ; 25 mg i.m.; The Upjohn Company, Kalamazoo, MI) given 24 h before removal of the implant. Cows were observed for estrus twice daily (0600 to 0700 and 1800 to 1900) following removal of the implant. Tail heads were painted (Impervo, Benjamin Moore and Co., Montvalo, NJ) and chalked (All-weather Paintstick, LA-CO Industries, Chicago, IL) as an aid for estrus detection (Macmillan et al., 1988) . To ensure that ovulatory follicles would all be at the same stage of development and therefore not be an additional source of variation in the steroidogenic capacity of the original CL, cows were given a second injection of PGF 2a (25 mg i.m.) on d 6 after synchronized estrus to induce ovulation of a first-wave dominant follicle at the same stage of follicular growth (Kastelic et al., 1990; Savio et al., 1990) .
After detection of this second estrus, 12 cows were assigned randomly to three treatment groups ( T1, T2, and T3) . In T1 ( n = 4 ) cows were injected on d 5 ( d 0 = day of estrus) of the estrous cycle with 2 mL of a sterile saline solution; in T2 ( n = 4 ) cows were injected on d 5 of the estrous cycle with a GnRHagonist (Buserelin; 8 mg i.m.; Hoechst-Roussel AgriVet, Sommerville, NJ); in T3 ( n = 4 ) cows were treated on d 5 with an injection of hCG (1,000 IU i.v.; 2,000 IU, i.m.; Steris Laboratories, Phoenix, AZ). The hCG dose was divided with 1,000 IU given i.v. to simulate the quick elevation in LH that should occur at the time of the ovulatory surge, and 2,000 IU given i.m. to maintain the levels of LH-like activity for an extended period of time. On d 13, the induced CL was removed by flank laparotomy. Local and epidural anesthesia were performed using lidocaine (2% solution). A flank incision was made and the ovaries were visualized. After identification (Ireland et al., 1980) , the induced CL was enucleated by exerting gentle pressure on the ovary. After bleeding from the ovary had stopped, the flank incision was sutured. The CL were transported immediately to the laboratory adjacent to the surgery room to be weighed and processed for culture of luteal slices and histological studies. Cows in the control group ( T 1 ) underwent a sham surgery, and a gentle pressure was exerted on the ovary bearing the original first-wave dominant follicle, without damaging any follicular or luteal structures. Ten milliliters of blood was collected daily from d 0 to d 13 and every 12 h from d 13 to d 17 by jugular venipuncture, into evacuated heparinized tubes (Vacutainer, Becton Dickinson Vacutainer systems, Rutherford, NJ). Blood was centrifuged immediately (3,000 × g for 20 min). Plasma was separated and stored at −20°C until assayed for progesterone. Transrectal ultrasonographic examinations of the ovaries of each cow were performed daily from d 0 to 17 with an Equisonic LS 1000 linear-array ultrasound scanner equipped with a 7.5-MHz transducer (Tokyo Keiki Co., Tokyo, Japan) to confirm presence of a first-wave dominant follicle, ovulation of the firstwave dominant follicle, and formation of an induced CL.
The second experiment was a replicate of the first experiment with 12 cows; however, the CL removed on d 13 were not studied. Instead, on d 17 the ovary bearing the original CL was removed by colpotomy (Drost et al., 1992) . Following ovariectomy the CL was enucleated, transported to the laboratory, and processed as for the first experiment. Experimental use of animals was approved by the University of Florida Institutional Animal Care and Use Committee.
Corpus Luteum Culture. After lutectomy, each CL was blotted dry, weighed, and sliced into 300-to 400-mg slices with a Stadie-Riggs hand microtome (Thomas Scientific, Atlanta, GA) on a plane perpendicular to the surface of the CL. All slices from a CL were placed in a Petri dish (100 × 20 mm) containing 20 mL of Dubelcco's Modified Eagle's Medium without phenol red ( DMEM) . Slices were washed by gently shaking the dish and then moved to another dish containing fresh medium. This process was repeated three times. Each slice was finally placed in an individual Petri dish (60 × 15 mm) containing 6.0 mL of DMEM. Weight of CL tissue in each dish was adjusted such that all slices weighed 250 mg. Eight slices were assigned randomly to one of four treatments in duplicate (one slice per dish): 1 ) control pre-incubation: 6 mL of absolute ethanol ( 4°C) was added to the culture dishes without incubation to stop progesterone synthesis (tissue and medium were immediately stored at −20°C); 2 ) control post-incubation: incubation with no treatment; 3 ) incubated with bovine-LH ( b-LH; 20 ng/mL; USDA B-5, Beltsville, MD), reconstituted in DMEM [100 ng/mL] and added to the culture to obtain a total volume of 6 mL; 4 ) incubated with b-LH (40 ng/mL). Petri dishes of the control post-incubation and the two b-LH treatments were incubated for 2 h (37°C; 5% CO 2 ) . At the end of the incubation period, absolute ethanol ( 6 mL, 4°C) was added to each Petri dish to terminate progesterone synthesis, and samples (culture medium + luteal slice + ethanol) were stored at −20°C until further assay of progesterone content.
Extraction of progesterone from the CL slices was performed according to the procedure described by Martin et al. (1990) and Slayden and Stormshak (1990) . Each sample had [ 3 H]progesterone (45,000 dpm) added before homogenization to assess procedural losses. Tissue plus medium in absolute ethanol were homogenized in a Duall 24 ground glass homogenizer. Homogenized samples were filtered through Whatman no. 1 filter paper. Homogenizer and filter were washed with an additional 5 mL of absolute ethanol. Filtered samples were evaporated to dryness under a gentle air stream in a 45°C water bath. Samples were reconstituted in 1 mL of PBS, vortexed, allowed to equilibrate for 30 min, and extracted with 10 mL of hexane/benzene (2:1). Samples were stored at −20°C overnight; the organic solvent was decanted and dried in a water bath at 45°C. The solvent residue was redissolved in 10 mL of absolute ethanol and 500 mL was quantified for radioactivity, after addition of 4 mL of Scintiverse ™ II (Fisher Scientific, Pittsburgh, PA) to estimate procedural losses. Average recovery was 87.3 ± 5.8%. From the final redissolved sample (10 mL), 100 mL was diluted (1/400) in PBS and 50 mL of the final dilution was assayed for progesterone.
Progesterone Radioimmunoassay. Radioimmunoassay for progesterone in plasma followed the protocol described by Knickerbocker et al. (1986) . The assay level of detection was .2 ng/mL. Intra-and interassay coefficients of variation were 8.5% and 6.5%, respectively. For the progesterone content of luteal slices, 200 mL of the diluted samples was assayed. High and low reference samples were generated by adding, respectively, 480 mg and 40 mg of progesterone (Steraloids, Wilton, NH) to 100 mL of absolute ethanol to obtain a final concentration after dilution in PBS (1/400) of 12 ng/mL (High) and 1 ng/mL (Low) of progesterone. Samples were assayed (50 mL ) without the extraction procedure described by Knickerbocker et al. (1986) . Intra-and interassay coefficients of variation were 7.29% and 3.9%.
Light Microscopy. Fresh CL slices ( 1 mm thick) were dissected into 5-× 5-mm pieces, fixed overnight in neutral buffered formalin (Sheenan and Hrapchack, 1980) , and embedded in paraffin. Four sections ( 5 mm thickness) were cut from the paraffin blocks such that each section was from a different region of the block. The sections were placed on glass slides and stained with hematoxylin and eosin (Sheenan and Hrapchack, 1980) for morphological evaluation. Three areas of each section were photographed with a light photomicroscope and the negatives printed to a final magnification of 300×. Each photograph ( n = 12/ animal) represented an area of 17,250 mm 2 . Various luteal cell parameters were evaluated from these photographs. First, size of 100 large and small luteal cells and the number of cells in each size category were determined. Small luteal cells were considered to be those < 20 mm in diameter and large luteal cells were considered those > 20 mm in diameter. Second, the number of small and large luteal cells per surface area of each section was determined. Measurements were conducted with a Zeiss Videoplan (Georgia Instruments, Atlanta, GA).
Electron Microscopy. Luteal tissues were processed for electron microscopic evaluation as described previously (Fields et al., 1992) . Briefly, the tissue was placed in 2% glutaraldehyde in .1 M cacodylate buffer (pH 7.4) overnight at 4°C, rinsed with cacodylate buffer, and post-fixed with 2% osmium tetroxide ( 2 h). Following rinsing with cacodylate buffer, the tissues were dehydrated with successive washings of ascending concentrations of ethanol (50% to 100%), ethanol:acetone (1:1), acetone (100%), acetone: Spurr's plastic (1:1), Spurr's plastic (100%), and embedded in Spurr's plastic. Ultrathin sections (.1 mm thickness) were cut, placed on copper grids, and stained with lead citrate and uranyl acetate. Luteal cells from the stained sections were photographed with a Philips 301 electron microscope (Philips Electronic Instruments, Mahwah, NJ) in order to evaluate the morphology of the luteal cells. Small and large luteal cells were categorized within three stages of development as described in the results. Percentages of cells within each stage were determined by electron microscopic evaluation of 150 large and small luteal cells from corpora lutea of each treatment (i.e., 50 large and small luteal cells each from CL of each of three cows per treatment).
Statistical Analyses. Data were analyzed using the General Linear Model Procedure of SAS (1988) . Plasma concentrations of progesterone were analyzed using a model that examined the effects of treatment, experiment, cow(treatment experiment), day of the experiment, and higher-order interactions; because cow was considered as a random effect, the effect of treatment and experiment were tested against cow(treatment experiment). Variances were not homogeneous for the different treatments ( P < .001) and a log 10 transformation was applied to the data in order to establish homogeneity of variances. No effect of experiment or experiment × treatment interaction was detected. In order to estimate the contrast to compare the means of the different treatments, a reduced mathematical model that excluded the effect of experiment was used. For ease of presentation, data are plotted untransformed and the respective SEM presented for each treatment. Progesterone production by CL slices was analyzed with a model that examined the effects of treatment, cow(treatment), dose of LH, and the interaction of treatment with dose. The size of small and large luteal cells as evaluated by light microscopy was analyzed for the effect of treatment and cow(treatment). Number of luteal cells per surface area was analyzed with a mathematical model that examined effects of treatment, cow (treatment), class (i.e., small or large luteal cells), photographic replicate (cow treatment), and higher-order interactions. The percentage of small and large luteal cells within each stage of development as evaluated by electromicroscopy was analyzed with a mathematical model that examined the effects of treatment, cow (treatment), stage of development, class (i.e., small or large luteal cells), and higher-order interactions.
Results

Corpus Luteum Weight
In both experiments, all heifers treated with a GnRH-agonist or hCG injection on d 5 of the estrous cycle ovulated and formed an induced CL as confirmed by ultrasonography. There was an acute disappearance of the dominant follicle and subsequent appearance of a CL at the same location on the ovary. Administration of hCG induced a heavier accessory CL compared to the accessory CL formed after injection of GnRH-agonist ( P < .04; Table 1 ). Weights of original CL removed on d 17 after treatments did not differ between treatments (Table 1) .
Plasma Concentration of Progesterone
When the data set was examined from d 0 to 17, d 0 to 5, d 6 to 13, and d 14 to 17, there was no effect of experiment or interaction of experiment with treatment on plasma concentrations of progesterone. 
Progesterone Production In Vitro
Induced Corpora Lutea on Day 13. There was no treatment difference in concentrations of progesterone of luteal slice before incubation (Figure 2, top panel) . However, the quantity of progesterone extracted from the slices of induced CL and secreted into the culture medium ( mg per g of CL tissue) after 2 h of incubation was influenced by treatment .8] vs hCG [172.0 ± 15.8]; P < .04) and dose of LH (ng/mL) in culture medium ( 0 [111.5 ± 12.3] vs 20 and 40 [156.43 ± 12.3] ; P < .02). The concentration of progesterone in the hCG-induced CL was always higher than for the GnRH-agonist induced CL for all doses of LH in culture medium, so there was no interaction of treatment × dose of LH. When progesterone extracted from luteal slices before incubation was adjusted for total weight of CL (Figure 2, Original Corpora Lutea on Day 17. There was no effect of treatment on progesterone concentration of CL slices ( mg/g) before or after incubation (Figure 3,  top panel) . The original CL removed on d 17 did not respond to in vitro incubation with LH for a Concentrations of progesterone differed with treatment (P < .04) and dose of LH in culture medium after a 2-h incubation (P < .02) but no differences were detected before incubation. Bottom panel: quantity of progesterone extracted was adjusted for luteal weight (bottom panel). Total progesterone content differed before incubation (P < .02). Similarly progesterone content of the CL after a 2-h incubation differed with treatment (P < .02) and was increased with the LH doses in culture medium (P < .06). Total progesterone content differed before incubation (P < .08). No differences were detected after incubation among treatment groups.
2-h period. Progesterone content of CL tissue ( mg/CL) before incubation was increased by treatment with hCG or GnRH-agonist (T1 [449.4 ± 125.1] < T2, T3 [746.4 ± 125.1]; P < .08). However, no effect of treatment or dose of LH in the culture medium was detected when the quantity of progesterone extracted from the luteal slices and secreted in the medium was expressed per total weight of CL (Figure 3 , bottom panel).
Light Microscopy
Induced Corpora Lutea on Day 13. There were no differences in the number of small or large luteal cells per 17,250 mm 2 of CL induced after treatment with GnRH-agonist or hCG (Table 2) . However, the average size of small luteal cells was increased for CL induced with hCG (13.5 ± .37 mm ) compared with those induced by GnRH-agonist (10.3 ± .34 mm; P < .001). There was no difference in the average size of large luteal cells between the two treatments.
Original Corpora Lutea on Day 17. No differences
were detected in the number of small or large luteal cells from original CL exposed to either saline, GnRHagonist, or hCG on d 5 ( 
Electron Microscopy
Two types of luteal cells, large (> 20 mm diameter) and small ( 8 to 20 mm diameter), were identified. These cells seemed to go through three stages of development leading up to a fourth stage or regression. Although there are no cell markers to demonstrate that only one type of small and large luteal cell exists, each progressing through the same three morphological stages, the changes in percentage of cells within each stage were associated with age of corpus luteum and treatments.
Stage 1 luteal cells are the most prominent cells in the induced CL, which is an 8-d-old CL. Large luteal cells ( Figure 4A ) contain numerous mitochondria with intact cristae, a smooth endoplasmic reticulum that is indistinct or slightly distended, and an oval nucleus. A distinct cluster of secretory granules was observed in 95% of these cells. Small luteal cells ( Figure 4B ) look like Stage 1 large cells except for their smaller size and fewer mitochondria and secretory granules. Junctional complexes between adjacent small cells ( Figure 5 ) were not observed between large cells.
Stage 2 luteal cells were most prominent in the original CL of hCG-and GnRH-agonist-treated cows compared to control CL on d 17 (Table 3) . The large and small luteal cells of stage 2 have a more dilated smooth endoplasmic reticulum than do those of Stage 1 and the nucleus is more pleomorphic in shape ( Figure 6 ). Stage 1 and 2 cells can be found adjacent to each other ( Figure 7A and 7B), indicating that the morphology reflects inherent properties of the cell in response to processing procedures. The mitochondria of the large luteal cells designated as Stage 2 have begun to accumulate electron-dense material ( Figure  7C) ; furthermore, 90% of the Stage 2 large luteal cells still contain a cluster of secretory granules.
Stage 3 luteal cells were the most abundant cell type in the CL of the d-17 untreated cow (Table 3 ) and seemed to be in the final stages of cell involution prior to Stage 4 (regression). Stage 3 cells have a very dilated smooth endoplasmic reticulum, a nucleus with a greatly distorted shape, and dilated mitochondria with undiscernible cristae ( Figure 8A ). A cluster of secretory granules was observed in fewer than 50% of Fricke et al. (1993) hypothesized that most of the progesterone increase observed from d 8 to 13 after treatment with hCG on d 6 of the estrous cycle was due to an effect of hCG on the original CL. Results of the present experiment do not agree with this hypothesis. The elevation in plasma concentrations of progesterone after induction of an induced CL, with administration of a GnRH-agonist or hCG on d 5 of the estrous cycle, seems to be due to the progesterone produced by the induced CL. This is implied because plasma progesterone did not differ among the three treatment groups after removal of the induced CL. Effect of hCG or GnRH-agonist administration on the original CL should not be excluded (Veenhuizen et al., 1972; Martin et al., 1990) , but the consequences of these effects on plasma progesterone could not be detected between d 14 and 17 with the present experimental design.
Discussion
Little information is available on plasma concentrations of progesterone after induction of an induced CL with an injection of a GnRH-agonist in cycling cows. Twagiramungu et al. (1995) did not detect any increase in plasma progesterone during the 6 d after induction of an induced CL with administration of a GnRH-agonist on d 7 after estrus. Martin et al. (1990) administered 100 mg of natural GnRH on d 2 and 8 of the estrous cycle and did not detect any increase in plasma progesterone in the treated animals, but they failed to mention whether induction of induced CL occurred. In the present experiment, rate of increase of plasma progesterone from d 6 to d 13 in GnRH-agonist treated animals was greater than for control. Therefore, the suppressive action of GnRH administered earlier during metestrus on CL function (Ford and Stormshak, 1978; Lucy and Stevenson, 1986; Rodger and Stormshak, 1986) was not observed in this study. The increased steroidogenicity of the hCG-induced CL may be due to different causes. Administration of hCG induces an increase in LH-like activity (Seguin et al., 1977; Schmitt et al., 1996) for a longer period of time (30 h ) compared to the length of the LH-surge ( 5 h ) elicited by an injection of a GnRH-agonist (Chenault et al., 1990) . Furthermore, the rate of internalization of hCG bound to the LH receptor on ovine luteal cells ( tØ = 22.8 h ) is much slower than that of ovine-LH ( tØ = 0.4 h). Because internalization of the LH receptor bound to its ligand is the mechanism used by the luteal cell to terminate a response to the gonadotropin hormone (Niswender et al., 1985) , the slower rate of internalization of the hCG-LH receptor complex is probably responsible for increased plasma progesterone secretion observed when ovine luteal cells are treated with hCG. Therefore, the longer half-life of hCG in the blood and slower turnover of the hCG-LH receptor complex on the surface of granulosa cells is likely responsible for an increased gonadotropic stimulation on the d-5 ovulatory follicle and its subsequent differentiation into a CL with a greater progesterone secreting capacity. Secretion of LH is essential for development of a fully functional CL during metestrus (Burke et al., 1994; Peters et al., 1994) . The persistence of hCG in plasma and on the cell surface may provide more optimal gonadotropic support for greater growth of the induced CL that is formed from a follicle that has not been LH-primed, as is the case of a proestrous follicle at d 0. In contrast, treatment with a GnRH-agonist elevates plasma concentrations of LH for only 5 h. Furthermore, after d 5 of the estrous cycle, progesterone produced by the growing original CL has a negative effect on the frequency of LH pulses from the pituitary (Rahe et al., 1980; Savio et al., 1993) . This would reduce original gonadotropic support necessary for functional development of the CL induced after ovulation of the first-wave dominant follicle by GnRHagonist. These two factors may explain the different progesterone secreting potentials of hCG-and GnRHagonist-induced CL.
Progesterone content ( mg/CL) of the induced CL before incubation was greater for the hCG-induced CL. Because the hCG-induced CL were heavier and there were no differences in the number of luteal cells (small and large) per surface area between T2 and T3, it can be concluded that the larger accessory CL induced by hCG contained more luteal cells than the CL induced by the GnRH-agonist. During the process of differentiation of the follicular cells into luteal cells, granulosa cells differentiate into large luteal cells (Smith et al., 1994) . No mitosis occurs during the differentiation of granulosa cells (Donaldson and Hansel, 1965; Zheng et al., 1994) , and number of granulosa cells in the preovulatory follicle is the same as the number of large luteal cells after CL formation (Smith et al., 1994) . However, intense mitotic activity is observed in theca-derived cells from d 1 to d 4 of the estrous cycle (Donaldson and Hansel, 1965; Zheng et al., 1994) , and it is likely that theca cells differentiate into small luteal cells (Donaldson and Hansel, 1965; Alila and Hansel, 1984; Meidan et al., 1990) .
It was suggested that small luteal cells also may originate from a population of stem cells composed of luteal fibroblasts (Niswender et al., 1985) and that during the estrous cycle small luteal cells may differentiate into large luteal cells. These processes are controlled by LH stimulation (Farin et al., 1988) . Perhaps differentiation of fibroblasts into small luteal cells, transformation of small luteal cells into large luteal cells, and increased mitogenic activity of the theca cells are all enhanced under increased LH-like stimulation due to hCG. This would explain augmentation of luteal weights observed for the hCG-treated animals, without a decrease in number of small and large luteal cells per surface area. It must also be noted that CL induced after administration of hCG (Fricke et al., 1993) or GnRH (Webb, et al., 1992) on d 6 of the estrous cycle do not differ in luteal weight from naturally occurring CL of the same age.
In vitro culture of the induced CL showed that both hCG or GnRH-agonist induced a functional CL. These results confirm those reported by Fricke et al. (1993) and Webb et al. (1992) for hCG-and GnRH-induced CL, respectively. However, LH-stimulated progesterone production was greater for the hCG-induced CL on a per gram of tissue basis. Only the small luteal cells have receptors for LH and respond to LH stimulation with an increase in progesterone production (Niswender et al., 1985) , and this may indicate an increased steroidogenic potential of the small luteal cells. In fact, morphometrical analysis of the luteal cells showed that small cells were larger for the hCGinduced CL.
The characteristics of the small and large luteal cells were similar to those previously reported (Fields et al., 1985 (Fields et al., , 1992 Weber et al., 1987) . Stage 1 are the most abundant cell type early in the estrous cycle (8-d-old induced CL). Except for the smaller size and the presence of junctional complexes between adjacent cells, the small cells look like large cells. Several investigators have suggested that small cells develop into the large cells and that during the estrous cycle small luteal cells constantly replenish the pool of large luteal cells (Donaldson and Hansel, 1965; Cran, 1983; Alila and Hansel, 1984; Farin et al., 1988) .
A higher percentage of Stage 1 luteal cells were observed early in the estrous cycle (d-8 induced CL), whereas a higher percentage of Stage 3 luteal cells occurred later in the estrous cycle ( d 17 untreated). The morphology of Stage 2 and 3 luteal cells is similar to those observed in luteal involution before regression reported in beef cattle (Fields et al., 1992) . In beef cattle, luteal cells from 8-d-old CL are healthiest, as indicated by a peak in number of secretory granules and in secretion of oxytocin. Day 17 of the estrous cycle is a time when the CL is undergoing involution before regression, as indicated by swollen mitochondria with a loss of their cristae and an accumulation of osmiophilic material (Fields et al., 1992) . These results are consistent with the observation that, during the estrous cycle, Stage 2 and Stage 3 luteal cells are more susceptible to subluteolytic doses of PGF 2a , as indicated by their depletion of oxytocincontaining secretory granules . Under these conditions, secretory granules and mitochondria of the Stage 1 were not affected. Stage 4 (regression) would be characterized by a large accumulation of lipid droplets, the complete loss of secretory granules, cell degeneration, and the accumulation of collagen bundles among degenerating cells (Fields et al., 1992) .
In Stage 3, the swelling of mitochondria and loss of cristae is likely due to an increased permeability of luteal cells that increases their sensitivity to changes in osmotic conditions during fixation. Properly fixed Stage 1 cells could be found adjacent to Stage 3 cells, indicating proper fixation and embedding for a normal, healthy cell.
In the original CL ( d 17) of the hCG-and GnRHagonist-treated cows, there was a larger percentage of Stage 1 and 2 luteal cells than in the CL from untreated cows ( d 17). These observations suggest that the additional LH-like exposure delayed progression of small and large luteal cells through the stages of development leading to the involution and regression processes. Perhaps extension of the CL lifespan when cows are treated with LH during the second part of the estrous cycle is due to this effect of LH (Donaldson and Hansel, 1965) . This retardation in development of Stage 3 luteal cells of original CL treated with hCG and GnRH-agonist may be associated with several factors. The higher CL content of progesterone in unincubated tissue for hCG and GnRH-agonist treatment (Figure 2 ) indicated that CL involution was indeed retarded. Diaz et al. (1993) demonstrated that cattle treated with hCG on d 5 all had three-wave follicle cycles and a slightly longer estrous cycle. Therefore, a delay in luteolytic signaling (e.g., estradiol and PGF 2a ) may have occurred, and this is reflected by the lower frequency of Stage 3 luteal cells in hCG-and GnRH-agonist-treated cows.
No major differences in morphological characteristics of luteal cells (e.g., distribution of Stage 1 and Stage 2 ) were detected between hCG-and GnRHinduced CL. Thus, the increased capacity of hCGinduced CL to secrete progesterone (in vivo and in vitro) is related to increased number of luteal cells associated with a greater tissue weight and a greater sensitivity to LH that is not reflected by the distribution of Stage 2 and Stage 3 luteal cells (small or large). Perhaps a greater number of LH receptors resides on the small luteal cells of hCG-induced CL. However, none of the experimental approaches examined this possibility. In cattle, progesterone secretion by the large luteal cells is not increased with LH stimulation . The role of the LH receptors identified on bovine large luteal cells (Chegini et al., 1991) may be to prevent progression of the cells through stages of development leading to regression of the corpus luteum.
In vitro incubation did not detect any treatment differences (hCG vs GnRH-agonist) in basal or LHstimulated progesterone production of luteal slices of the naturally occurring CL ( mg progesterone/g CL) removed on d 17. Furthermore, no differences were detected in progesterone secretion per CL. Comparable rates of in vitro progesterone secretion by original CL would account for the similar plasma concentrations of progesterone in vivo after the induced CL were removed. However, before incubation the original CL in GnRH-agonist-and hCG-treated cows contained more progesterone than that of the control group. Furthermore, size of the small and large luteal cells were increased for the cows treated with hCG or the GnRH-agonist. This is consistent with other reports in ewes (Farin et al., 1988) in which size of luteal cells of the original CL is increased after treatment with pharmacological doses of hCG or LH. This may be indicative of healthier (Stage 1 ) luteal cells.
Implications
Ovulation of the first-wave dominant follicle on d 5 of the estrous cycle after administration of a gonadotropin-releasing hormone (GnRH)-agonist or human chorionic gonadotropin (hCG) induced a functional corpus luteum (CL) responsible for the subsequent increases in plasma progesterone. The extended luteinizing hormone (LH)-like stimulation due to the injection of hCG produced a larger and more steroidogenic CL. Development of new pharmacological forms and delivery systems of GnRH to extend the release period of LH to replace hCG, a potentially immunogenic molecule, warrants investigation. Of interest is the observation that luteal cells progress sequentially through three morphological stages before regression. This process could be delayed by the action of LH.
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